No Data
No Data
No Data
No Data
No Data
XinTong Medical-B (02160): Vitaflow Liberty receives CE mark approval
Xintong Medical-B (02160) announced that VitaFlow Liberty, independently developed by the group...
Zhitong FinanceApr 25 10:10 ET
Microport Cardioflow Inks Services Deal With Subsidiary
Microport Cardioflow Medtech (HKG:2160) agreed to provide supporting services to its 51%-owned unit Shanghai MicroPort CardioAdvent for 2021, according to a Monday filing with the Hong Kong bourse. Th
MT NewswiresApr 16 07:29 ET
Xintong Medical-B (02160.HK) signs 2024 Shanghai Jiuxin Service Procurement Framework Agreement
Gelonghui, April 15, 丨 Xintong Medical-B (02160.HK) announced that on April 15, 2024, the company (for itself and its subsidiaries, joint ventures and associated companies other than Shanghai Zuxin) entered into a 2024 Shanghai Jiuxin Service Procurement Framework Agreement for the period beginning on the 2024 Shanghai Jiuxin Service Procurement Framework Agreement and ending on December 31, 2025. According to this, Shanghai Zuxin will procure certain services from the company and its subsidiaries, joint ventures and associated companies other than Shanghai Jiuxin.
Gelonghui FinanceApr 15 06:01 ET
Xintong Medical-B granted a total of 14.3238 million share options
Xintong Medical-B (02160) issued an announcement. On April 8, 2024, the company decided to grant share options to eligible participants in accordance with the share plan adopted by the company on June 27, 2023 to subscribe for common shares of the company with a face value of $0.000005 per share of up to 14.3238 million shares of the company's share capital, but this can only be realized after acceptance by the grantor. The exercise price for which the share options were granted was HK$1.002 per share.
新浪港股Apr 8 19:35 ET
Xintong Medical-B (02160) granted a total of 14.3238 million share options
Zhitong Finance App News, Xintong Financial App (02160) issued an announcement. On April 8, 2024, the company decided to grant share options to eligible participants in accordance with the share plan adopted by the company on June 27, 2023 to subscribe for up to 14.323,800 shares of the company's common shares with a face value of 0.000005 US dollars per share in the company's share capital, but only after acceptance by the grantor. The exercise price for which the share options were granted was HK$1.002 per share.
Zhitong FinanceApr 8 10:47 ET
MicroPort CardioFlow Medtech Corporation's (HKG:2160) Share Price Not Quite Adding Up
MicroPort CardioFlow Medtech Corporation's (HKG:2160) price-to-sales (or "P/S") ratio of 6.1x may look like a poor investment opportunity when you consider close to half the companies in the Medical E
Simply Wall StApr 4 18:10 ET
No Data
No Data